Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 2
This trial is looking at gemcitabine and carboplatin chemotherapy with a new drug called apatorsen for people with non small cell lung cancer (NSCLC) that has spread. It is for people with a type of NSCLC called squamous cell lung carcinoma. The trial is supported by CRUK.
Recruitment start: 26 July 2014
Recruitment end: 22 December 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Schmid
Barts Cancer Institute
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Oncogenex Pharmaceuticals Inc
Queen Mary University of London
This is Cancer Research UK number CRUKE/13/014
Last reviewed: 10 March 2017
CRUK internal database number: 10902
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
